A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

Starting soon · Not applicable

Conditions studied: Cancer, Breast Cancer

In brief

In this pilot study, the investigators will assess the changes in myokine production based on several different exercise regimens.

Key facts

Study ID

NCT07698314

Run by

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

People needed

21

Starts

2026-06-01

Expected to finish

2028-06-01

Last updated by the study team

2026-07-13

Who can join

Age: 20 and older, up to 89. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 20-89 years
• Women prescribed exercise as a SOC
• Women with a biopsy proven diagnosis of ductal carcinoma in situ (DCIS) or invasive carcinoma of the breast
• Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
• Women with > 3 months of resistance training experience under expert guidance at the Allegheny Health Network Exercise Oncology Center

You may not qualify if…

• Any current treatment with cytotoxic chemotherapy for breast cancer
• Inability to safely engage in group sessions of resistance training as deemed by study PI
• Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training
• Pregnant women
• Males

Where it is running

• AHN Allegheny General Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.